LOCALIZATION OF INTESTINAL INTERLEUKIN-1 ACTIVITY AND PROTEIN AND GENE-EXPRESSION TO LAMINA PROPRIA CELLS

被引:194
作者
YOUNGMAN, KR
SIMON, PL
WEST, GA
COMINELLI, F
RACHMILEWITZ, D
KLEIN, JS
FIOCCHI, C
机构
[1] CLEVELAND CLIN FDN,RES INST NNI-26,9500 EUCLID AVE,CLEVELAND,OH 44195
[2] CIBA GEIGY CORP,DIV PHARMACEUT,SUMMIT,NJ 07901
[3] HADASSAH UNIV HOSP,IL-91120 JERUSALEM,ISRAEL
[4] UNIV SO CALIF,LOS ANGELES,CA 90089
关键词
D O I
10.1016/0016-5085(93)91010-F
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Interleukin 1 (IL-1) is a key mediator of bowel inflammation, but there is limited knowledge about the amount and site of production of this cytokine in the gastrointestinal tract under physiological or pathological conditions. Methods: Epithelial and lamina propria mononuclear cells were isolated from control, and Crohn's disease- and ulcerative colitis-involved mucosa to investigate the capacity of these cells to generate IL-1 bioactivity, IL-1α and IL-1β immunoreactivity, and gene expression. Results: Control lamina propria mononuclear cells produced substantial amounts of IL-1α and IL-1β, which increased dramatically when inflammatory bowel disease cells were used. Epithelial cells from control, Crohn's disease, and ulcerative colitis intestine displayed no IL-1 bioactivity or immunoreactivity. Lamina propria mononuclear cells contained moderate to large quantities of IL-1α and IL-1β messenger RNA (mRNA), respectively, whereas epithelial cells had none. The absence of IL-1 transcripts in epithelial cells was selective, because mRNA for HLA-DR antigens was present in control and inflammatory bowel disease cells. Conclusions: In normal and inflamed human intestine there is a distinct compartmentalization of IL-1, as mononuclear but not epithelial cells generate this cytokine. The high levels of IL-1 in inflammatory bowel disease may explain several of its local and systemic manifestations, and blockade by specific antagonists could have important therapeutic effects. © 1993.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 51 条
[1]   INTERLEUKIN-1 AND INTERLEUKIN-2 ACTIVITY IN CHRONIC HEPATITIS-B VIRUS-INFECTION [J].
ANASTASSAKOS, C ;
ALEXANDER, GJM ;
WOLSTENCROFT, RA ;
AVERY, JA ;
PORTMANN, BC ;
PANAYI, GS ;
DUMONDE, DC ;
EDDLESTON, ALWF ;
WILLIAMS, R .
GASTROENTEROLOGY, 1988, 94 (04) :999-1005
[2]   ENRICHMENT OF MACROPHAGES IN CELL-SUSPENSIONS OF HUMAN INTESTINAL-MUCOSA BY ELUTRIATION CENTRIFUGATION [J].
BEEKEN, W ;
MIEREMETOOMS, M ;
GINSEL, LA ;
LEIJH, PCJ ;
VERSPAGET, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 73 (01) :189-201
[3]   CYTOTOXICITY OF HUMAN PI-7 INTERLEUKIN-1 FOR PANCREATIC-ISLETS OF LANGERHANS [J].
BENDTZEN, K ;
MANDRUPPOULSEN, T ;
NERUP, J ;
NIELSEN, JH ;
DINARELLO, CA ;
SVENSON, M .
SCIENCE, 1986, 232 (4757) :1545-1547
[4]  
BLAND PW, 1986, IMMUNOLOGY, V58, P9
[5]  
BOCHNER BS, 1987, J IMMUNOL, V139, P2297
[6]   INHIBITOR OF INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA-INDUCED T-CELL ACTIVATION IN SERUM OF PATIENTS WITH ACTIVE CROHNS-DISEASE [J].
BRYNSKOV, J ;
HANSEN, MB ;
REIMERT, C ;
BENDTZEN, K .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (06) :737-742
[7]  
BUCKLEY TL, 1991, J IMMUNOL, V146, P3424
[8]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[9]   INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS [J].
COMINELLI, F ;
NAST, CC ;
CLARK, BD ;
SCHINDLER, R ;
LLERENA, R ;
EYSSELEIN, VE ;
THOMPSON, RC ;
DINARELLO, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :972-980
[10]   RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST BLOCKS THE PROINFLAMMATORY ACTIVITY OF ENDOGENEOUS INTERLEUKIN-1 IN RABBIT IMMUNE COLITIS [J].
COMINELLI, F ;
NAST, CC ;
DUCHINI, A ;
LEE, M .
GASTROENTEROLOGY, 1992, 103 (01) :65-71